Announcements Trials

Browse Landscape

Phase

Status

Unknown 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 67 Colonic Neoplasms 31 Rectal Neoplasms 30 Pancreatic Neoplasms 18 Stomach Neoplasms 16 Neoplasm Metastasis 14 Carcinoma, Hepatocellular 14 Esophageal Neoplasms 6 Leukemia 5 Neoplasms 4 Lymphoma 4 Liver Neoplasms 3 Gastrointestinal Neoplasms 3 Cholangiocarcinoma 3 Carcinoma 3 Adenocarcinoma Of Esophagus 3 Solid Tumors 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Neutropenia 2 Leukemia, Biphenotypic, Acute 2 Gallbladder Neoplasms 2 Digestive System Neoplasms 2 Colorectal Cancer Metastatic 2 Carcinoma, Squamous Cell 2 Breast Neoplasms 2 Biliary Tract Neoplasms 2 Bile Duct Neoplasms 2 mCRC 1 Unresectable Sinonasal Tumors 1 Thymoma 1

Interventions

irinotecan sucrosofate 1 folfirinox 1 Taxes 1 Surgical Procedures, Operative 1 Radiotherapy 1 Radiosurgery 1 Oxaliplatin 1 Leucovorin 1 Gemcitabine 1 Folfox protocol 1 Fluorouracil 1 Albumin-Bound Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Pancreatic Adenocarcinoma × Leucovorin × Clear all

NCT03528785 2021-08-02

nITRo

Centro Ricerche Cliniche di Verona

Phase 2 Unknown

Gastrointestinal

Pancreatic Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡